,59 However, even though the PFC is a vulnerable region in tauopathies such as frontotemporal lobar degeneration (tau-FTLD) and AD, additional studies targeting other affected brain areas in different animal models will provide stronger evidence about the potential use of Tau-miRNAs. This evidence concerns the gene MAPT and Alzheimer disease.